Lyngby
Denmark
32
2013-10-31
16
2015-12-22
These are the the leading inventors for applications assigned to SYMPHOGEN A/S:
SYMPHOGEN A/S based in Lyngby, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Anti-HER3 antibodies and compositions
#2 | 2013-08-08 β Patent 9,029,091 granted on 2015-05-12Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
#3 | 2013-02-21ANTIBODY AGAINST SEROTYPE G LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#4 | 2013-01-24Method for Cloning Cognate Antibodies
#5 | 2013-01-24ANTIBODY AGAINST SEROTYPE B LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#6 | 2013-01-24ANTIBODY AGAINST SEROTYPE I LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#7 | 2013-01-03ANTIBODY AGAINST SEROTYPE A LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#8 | 2013-01-03ANTIBODY AGAINST SEROTYPE E LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#9 | 2012-12-20Anti-Rhesus D Recombinant Polyclonal Antibody and Methods of Manufacture
#10 | 2012-05-03 β Patent 9,155,802 granted on 2015-10-13Pan-HER antibody composition
#11 | 2011-09-22 β Patent 8,663,640 granted on 2014-03-04Methods using recombinant anti-epidermal growth factor receptor antibody compositions
#12 | 2011-09-08TREATMENT OF THROMBOCYTOPENIA
#13 | 2011-09-08 β Patent 8,609,095 granted on 2013-12-17Anti-HER2 antibodies and compositions
#14 | 2011-08-04RECOMBINANT ANTIBODIES FOR TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
#15 | 2011-06-30ANTI-ORTHOPOXVIRUS RECOMBINANT POLYCLONAL ANTIBODY
#16 | 2011-06-09 β Patent 8,414,896 granted on 2013-04-09Recombinant anti-epidermal growth factor receptor antibody compositions
#17 | 2011-06-02Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions
#18 | 2010-12-09Method for Linking Sequences of Interest
#19 | 2010-03-18Method for Cloning Avian-Derived Antibodies
#20 | 2010-02-18Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
#21 | 2009-05-28 β Patent 9,163,232 granted on 2015-10-20Method for manufacturing recombinant polyclonal proteins
#22 | 2009-04-30 β Patent 7,910,332 granted on 2011-03-22Method for manufacturing a recombinant polyclonal protein
#23 | 2009-04-09POTENCY ASSAY
#24 | 2009-01-15 β Patent 8,198,415 granted on 2012-06-12Anti-rhesus D recombinant polyclonal antibody
#25 | 2009-01-01 β Patent 7,887,805 granted on 2011-02-15Recombinant anti-epidermal growth factor receptor antibody compositions
#26 | 2008-09-18 β Patent 8,283,294 granted on 2012-10-09Method for cloning cognate antibodies
#27 | 2008-09-18 β Patent 7,879,329 granted on 2011-02-01Recombinant antibodies for treatment of respiratory syncytial virus infections
#28 | 2008-06-05 β Patent 8,288,109 granted on 2012-10-16Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
#29 | 2008-03-20 β Patent 7,850,965 granted on 2010-12-14Anti-orthopoxvirus recombinant polyclonal antibody
#30 | 2007-06-21 β Patent 7,749,697 granted on 2010-07-06Method for linking sequences of interest
#31 | 2005-08-18Polyclonal antibody composition for treating allergy
#32 | 2005-02-01 β Patent 6,849,259 granted on 2005-02-01Polyclonal antibody composition for treating allergy
Also check out Symphogen A/S's (Lyngby, Denmark) applicant profile with 1 patent applications submitted.
1534 β